Jungtiniai Arabų Emyratai - anglų - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c netherlands - 250ml can - liquid - combination - nutrition , blood-oral nutrition

Jungtiniai Arabų Emyratai - anglų - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c netherlands - 250ml can - liquid - combination - nutrition , blood-oral nutrition

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

flavour not specified - gastroenteral or oral liquid

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott laboratories ltd - gastroenteral or oral liquid

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott laboratories ltd - gastroenteral or oral liquid

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott laboratories ltd - gastroenteral or oral liquid

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott laboratories ltd - gastroenteral or oral liquid

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott laboratories ltd - gastroenteral or oral liquid

Australija - anglų - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - carbamazepine, quantity: 20 mg/ml - oral liquid, suspension - excipient ingredients: hyetellose; methyl hydroxybenzoate; purified water; dispersible cellulose; propyl hydroxybenzoate; sorbitol solution (70 per cent) (non-crystallising); peg-8 stearate; sorbic acid; propylene glycol; saccharin sodium; flavour - 1. epilepsy: complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalisation; generalised tonic-clonic seizures; mixed seizure patterns incorporating the above. tegretol is suitable for monotherapy and combination therapy. tegretol is usually not effective in absence seizures, atonic seizures and myoclonic seizures and should not be used for status epilepticus (see "precautions"). 2. trigeminal neuralgia: for relief of pain in idiopathic trigeminal neuralgia and trigeminal neuralgia due to multiple sclerosis; and in idiopathic glossopharyngeal neuralgia. (tegretol is not a simple analgesic and is not intended for trivial facial pain or headache). 3. mania and bipolar affective disorders: treatment of mania and maintenance treatment of bipolar affective disorders to prevent or attenuate recurrence.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

pharmaco australia ltd - clonazepam, quantity: 2.5 mg/ml - oral liquid, solution - excipient ingredients: saccharin sodium; propylene glycol; brilliant blue fcf; glacial acetic acid; flavour - tablets. most types of epilepsy in infants and children, especially absences (petit mal), myoclonic seizures and tonic-clonic fits, whether due to primary generalised epilepsy, or to secondary generalisation of partial epilepsy. in adults all varieties of generalised epilepsy, (including myoclonic, akinetic, tonic and tonic-clonic seizures), and in partial epilepsy (including psychomotor seizures). injection. intravenous use for status epilepticus only. note. efficacy by the intramuscular route has not need demonstrated.